Deng Qian, Chen Yuqing, Wang Xin, Cai Wenjuan, Han Yanping, Wang Juanjuan
Endocrine Metabolism Department, Anhui Provincial Children's Hospital, Hefei 23000, Anhui, China.
Evid Based Complement Alternat Med. 2022 Sep 14;2022:2862682. doi: 10.1155/2022/2862682. eCollection 2022.
To compare the clinical efficacy of different insulin administration methods and blood glucose monitoring methods in treating type 1 diabetes mellitus in children.
Patients were divided into four groups: multiple daily injection (MDI) + fingertip blood glucose detection, continuous subcutaneous insulin infusion (CSII) + fingertip blood glucose detection, MDI + continuous glucose monitoring system (CGMS), and CSII + CGMS. After six months of treatment, followed by telephone and at least once a month in an outpatient clinic, insulin doses were adjusted according to the children's blood glucose levels. Blood glucose control and the daily dose of insulin were compared among the four groups after treatment, and the incidence of hypoglycemia in each group was recorded during the treatment. We also compare the incidence of the adverse event among the four groups.
6 months later, the levels of HbA1c, FBG, and two h PG in each group were lower than those before treatment. There were significant differences in HbA1c, two h PG, and the daily insulin dose among the four groups. There were differences in the frequency of hypoglycemia among all the groups. The frequency of hypoglycemia in groups C and D was lower than in group A.
CSII was better than MDI, and the blood glucose monitoring effect of CGMS was better than the fingertip blood glucose detection. The patients treated with CSII combined with CGMS had the best clinical efficacy. The patients treated with CSII combined with CGMS had the lowest adverse events incidence.
比较不同胰岛素给药方法和血糖监测方法治疗儿童1型糖尿病的临床疗效。
将患者分为四组:多次皮下注射(MDI)+指尖血糖检测、持续皮下胰岛素输注(CSII)+指尖血糖检测、MDI+持续葡萄糖监测系统(CGMS)、CSII+CGMS。治疗6个月后,通过电话随访且门诊每月至少随访1次,根据患儿血糖水平调整胰岛素剂量。比较四组治疗后血糖控制情况及胰岛素日剂量,并记录治疗期间各组低血糖发生率。同时比较四组不良事件发生率。
6个月后,各组糖化血红蛋白(HbA1c)、空腹血糖(FBG)、餐后2小时血糖(2h PG)水平均低于治疗前。四组间HbA1c、2h PG及胰岛素日剂量比较差异有统计学意义。各组低血糖发生频率存在差异,C组和D组低血糖发生频率低于A组。
CSII优于MDI,CGMS血糖监测效果优于指尖血糖检测。CSII联合CGMS治疗的患者临床疗效最佳,不良事件发生率最低。